The Corporate Transparency Act (CTA) went into effect on January 1, 2024, and will impact millions of U.S. businesses by
Continue Reading The Corporate Transparency Act: What you Need to Know to Comply with the New Requirements
Meating of the Minds: Impossible Foods and Motif Foodworks Settle High Profile Patent Dispute in District Court
The food tech industry has been growing and evolving rapidly in the last ten years due to technological innovations in
Continue Reading Meating of the Minds: Impossible Foods and Motif Foodworks Settle High Profile Patent Dispute in District Court
Advanced IP Considerations for Cell-and-Gene Therapeutic Companies Utilizing Lipid Nanoparticle Delivery Systems
As I have written about previously, the IP and competitive landscape for mRNA and lipid nanoparticles is complex. Pioneers, mid-stage
Continue Reading Advanced IP Considerations for Cell-and-Gene Therapeutic Companies Utilizing Lipid Nanoparticle Delivery Systems
This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates
The Unted States Patent and Trademark Office (USPTO) recently published new guidance on subject-matter eligibility as related to Artificial Intelligence
Continue Reading This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates
USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of Dollars
Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO).
Continue Reading USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of Dollars
Client Spotlight: BASE Air Management
BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by
Continue Reading Client Spotlight: BASE Air Management
Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
How I Protected My Intellectual Property on a Lean Budget
Guest Post By Leena Chitnis, Founder & CEO, Timberdog®
In today’s fast-paced business environment, intellectual property (IP) has become
Continue Reading How I Protected My Intellectual Property on a Lean Budget